Neoadjuvant Therapy for Esophageal Cancer: Who, When, and What?

Cancer - United States
doi 10.1002/cncr.31768
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Quality of Life During Neoadjuvant Therapy for Patients With Esophageal Cancer

IOSR Journal of Nursing and Health Science
2017English

Sentinel Lymph Node in Esophageal Cancer Before Neoadjuvant Therapy

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2005English

Neoadjuvant Treatment Strategy for Locally Advanced Thoracic Esophageal Cancer

Annals of Gastroenterological Surgery
2019English

What Is the Role of Neoadjuvant Chemotherapy, Radiation, and Adjuvant Treatment in Resectable Esophageal Cancer?

Annals of Cardiothoracic Surgery
SurgeryCardiovascular MedicineCardiology
2017English

Multimodality Therapy for Esophageal Cancer

Oncologist
Cancer ResearchMedicineOncology
1996English

Vitamin D Receptor Expression and Neoadjuvant Therapy in Esophageal Adenocarcinoma

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2012English

Revisiting Radiation Therapy for Esophageal Cancer

Esophagus
Gastroenterology
2020English

Teaching and Learning Systems Thinking: What, Why, When, Where, Who, What For, How?

Revista Internacional de Sistemas
2018English

Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy